BMS 509744

Discontinued Product

BMS 509744 (Cat. No. 5009) has been withdrawn from sale for commercial reasons.
Description: Potent and selective ITK inhibitor
Chemical Name: N-[5-[[5-[(4-Acetyl-1-piperazinyl)carbonyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[[(1,2,2-trimethylpropyl)amino]methyl]benzamide
Purity: ≥97% (HPLC)
Citations (1)

Biological Activity for BMS 509744

BMS 509744 is a potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitor (IC50 = 19 nM). Displays 200-fold selectivity over Tec family kinases and 55-fold selectivity over other kinases tested. Reduces HIV infection of primary CD4+ T cells and attenuates the establishment of HIV infection in vitro. Reduces T cell proliferation and IL-2 production in vitro. Reduces lung inflammation in a mouse model of ovalbumin-induced allergy/asthma.

Compound Libraries for BMS 509744

BMS 509744 is also offered as part of the Tocriscreen Antiviral Library. Find out more about compound libraries available from Tocris.

Technical Data for BMS 509744

M. Wt 623.83
Formula C32H41N5O4S2
Storage Store at -20°C
Purity ≥97% (HPLC)
CAS Number 439575-02-7
PubChem ID 11467730
Smiles COC1=CC(C)=C(SC3=CN=C(NC(C4=CC=C(CNC(C)C(C)(C)C)C=C4)=O)S3)C=C1C(N2CCN(C(C)=O)CC2)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Product Datasheets for BMS 509744

Certificate of Analysis / Product Datasheet
Select another batch:

References for BMS 509744

References are publications that support the biological activity of the product.

Kutach et al (2010) Crystal structures of IL-2-inducible T cell kinase complexed with inhibitors: insights into rational drug design and activity regulation. Chem Biol Drug Des. 76 154 PMID: 20545945

Das et al (2006) Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors. Bioorg.Med.Chem.Lett. 16 3706 PMID: 16682193

Readinger et al (2008) Selective targeting of ITK blocks multiple steps of HIV replication. Proc.Natl.Acad.Sci.U.S.A. 105 6684 PMID: 18443296

View Related Products by Target

View Related Products by Product Action

View all ITK Inhibitors

Keywords: BMS 509744, BMS 509744 supplier, BMS509744, lung, inflammation, allergy, asthma, inducible, T, cell, kinase, emt, tsk, HIV, potent, selective, ITK, inhibitors, inhibits, Il2, 5009, Tocris Bioscience

1 Citation for BMS 509744

Citations are publications that use Tocris products. Selected citations for BMS 509744 include:

Mamand et al (2018) Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma. Sci Rep 8 14216 PMID: 30242208

Reviews for BMS 509744

There are currently no reviews for this product. Be the first to review BMS 509744 and earn rewards!

Have you used BMS 509744?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review